
TELA Bio, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance
2025-11-20 15:37:30TELA Bio, Inc. reported flat financial performance for the quarter ending June 2025, with notable achievements in operating cash flow and net sales. However, challenges persist, including low return on capital employed and a declining debtors turnover ratio, amid significant stock declines compared to broader market trends.
Read MoreIs TELA Bio, Inc. technically bullish or bearish?
2025-09-20 19:39:15As of 10 September 2025, the technical trend for TELA Bio, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish, driven by a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and a bearish signal from the Bollinger Bands on the monthly timeframe. Additionally, the KST and OBV indicators are both showing bearish trends on the monthly timeframe. In terms of performance, TELA Bio has significantly underperformed the S&P 500 across all multi-period returns, with a year-to-date return of -47.35% compared to the S&P 500's 12.22%....
Read More





